-
Founded in:
1995-02-20 -
Country:
China -
Address:
No. 99, Zhuhai Road, Limin Development Zone, Hulan District, Harbin -
Tax NO.:
91230111128024298B -
Registered Funds:
186.0655 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Recombinant Human Interferon α2b |
No specific description provided
More
No specific description provided |
0 | ||
| Human serum albumin |
No specific description provided
More
No specific description provided |
70024-90-7 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 14-deoxy-11,12-didehydroandrographolide 3,19-disuccinate |
|
76958-99-1 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Recombinant human interferon alpha;1b |
The average serum concentration of Anfulong is the same after intramuscular injection and subcutaneous injection, with the highest serum concentration of about 1.2-33.6 units/ml, occurring 1 to 24 hours later; the elimination half-life is 4-12 hours, and the maximum blood concentration occurs 3.5-8 hours after medication. It can make hepatitis B e antigen negative, normalize transaminase levels, reduce liver inflammation, and delay the progression to cirrhosis and improve the quality of life in 20%-30% of patients. It can normalize serum ALT, improve liver tissue and reduce the amount of virus in patients with chronic hepatitis C. It has clinical significance in tumor regression or stabilization of hairy cell leukemia, and in the treatment of patients with Kaposi's sarcoma related to AIDS. It is of great significance for patients with chronic myeloid leukemia, and can also be used as an adjunct to intermittent treatment of Philadelphia chromosome-positive chronic myeloid leukemia.
More
The average serum concentration of Anfulong is the same after intramuscular injection and subcutaneous injection, with the highest serum concentration of about 1.2-33.6 units/ml, occurring 1 to 24 hours later; the elimination half-life is 4-12 hours, and the maximum blood concentration occurs 3.5-8 hours after medication. It can make hepatitis B e antigen negative, normalize transaminase levels, reduce liver inflammation, and delay the progression to cirrhosis and improve the quality of life in 20%-30% of patients. It can normalize serum ALT, improve liver tissue and reduce the amount of virus in patients with chronic hepatitis C. It has clinical significance in tumor regression or stabilization of hairy cell leukemia, and in the treatment of patients with Kaposi's sarcoma related to AIDS. It is of great significance for patients with chronic myeloid leukemia, and can also be used as an adjunct to intermittent treatment of Philadelphia chromosome-positive chronic myeloid leukemia. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Prostaglandin E1 |
Dilate blood vessels, inhibit platelet aggregation; stabilize liver cell membranes and improve liver function
More
Dilate blood vessels, inhibit platelet aggregation; stabilize liver cell membranes and improve liver function |
745-65-3 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Prostaglandin E1 |
Dilate blood vessels, inhibit platelet aggregation; stabilize liver cell membranes and improve liver function
More
Dilate blood vessels, inhibit platelet aggregation; stabilize liver cell membranes and improve liver function |
745-65-3 | 14 |